Precision BioSciences reported a quarterly loss of $0.34 per share, wider than the Zacks Consensus Estimate loss of $0.27 per share. The result was still a major improvement from the $2.21 per-share loss a year ago, but it missed expectations by $0.07 per share. The update is modestly negative for the stock and likely to be market-relevant at the individual company level.
Precision BioSciences reported a quarterly loss of $0.34 per share, wider than the Zacks Consensus Estimate loss of $0.27 per share. The result was still a major improvement from the $2.21 per-share loss a year ago, but it missed expectations by $0.07 per share. The update is modestly negative for the stock and likely to be market-relevant at the individual company level.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.28
Ticker Sentiment
